Di Vincenzo, Federica
 Distribuzione geografica
Continente #
NA - Nord America 1.335
AS - Asia 711
EU - Europa 463
SA - Sud America 203
Continente sconosciuto - Info sul continente non disponibili 42
AF - Africa 12
OC - Oceania 1
Totale 2.767
Nazione #
US - Stati Uniti d'America 1.288
SG - Singapore 272
CN - Cina 174
IT - Italia 170
BR - Brasile 155
VN - Vietnam 90
DE - Germania 65
FR - Francia 49
GB - Regno Unito 35
FI - Finlandia 33
JP - Giappone 31
CA - Canada 29
HK - Hong Kong 27
BD - Bangladesh 22
KR - Corea 22
SE - Svezia 21
ID - Indonesia 15
AR - Argentina 14
IN - India 13
IE - Irlanda 12
PL - Polonia 11
RU - Federazione Russa 11
ES - Italia 10
IQ - Iraq 10
MX - Messico 9
CO - Colombia 8
EC - Ecuador 7
NL - Olanda 7
IL - Israele 5
AT - Austria 4
CH - Svizzera 4
CL - Cile 4
VE - Venezuela 4
ZA - Sudafrica 4
BE - Belgio 3
BY - Bielorussia 3
KG - Kirghizistan 3
NP - Nepal 3
PY - Paraguay 3
RO - Romania 3
SA - Arabia Saudita 3
UA - Ucraina 3
UY - Uruguay 3
AZ - Azerbaigian 2
BB - Barbados 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
IR - Iran 2
KE - Kenya 2
MK - Macedonia 2
MT - Malta 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
SI - Slovenia 2
TR - Turchia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NI - Nicaragua 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SR - Suriname 1
SV - El Salvador 1
TN - Tunisia 1
TO - Tonga 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.726
Città #
Singapore 153
San Jose 137
Ashburn 119
Los Angeles 55
Rome 50
Hefei 48
New York 39
Ho Chi Minh City 30
Tokyo 30
Hanoi 29
São Paulo 27
The Dalles 27
Beijing 26
Hong Kong 26
Council Bluffs 24
Lauterbourg 23
Dallas 22
Frankfurt am Main 21
Seoul 21
Boardman 19
Munich 19
Atlanta 14
Denver 14
North Bergen 14
Turku 14
Helsinki 13
Kent 13
Montreal 12
Chicago 11
Jakarta 11
Santa Clara 11
London 10
Nuremberg 10
Houston 9
Orem 9
Phoenix 9
Dublin 8
Düsseldorf 8
Poplar 8
St Louis 8
Stockholm 8
Warsaw 8
Rio de Janeiro 7
Lappeenranta 6
Milan 6
San Francisco 6
Seattle 6
Toronto 6
Baghdad 5
Boston 5
Moscow 5
Bogotá 4
Brooklyn 4
Cork 4
Detroit 4
Florence 4
Haiphong 4
Mumbai 4
Nanjing 4
Porto Alegre 4
Querétaro 4
Tel Aviv 4
Baronissi 3
Bishkek 3
Brasília 3
Brussels 3
Buffalo 3
Cagliari 3
Campinas 3
Da Nang 3
Elk Grove Village 3
Grazzanise 3
Guarulhos 3
Honolulu 3
Hyderabad 3
Manchester 3
Montevideo 3
Newark 3
Nha Trang 3
Portsmouth 3
Roubaix 3
Secaucus 3
Tampa 3
Zurich 3
Asunción 2
Atibaia 2
Baku 2
Biên Hòa 2
Bologna 2
Bridgetown 2
Bắc Ninh 2
Chennai 2
Columbus 2
Copenhagen 2
Curitiba 2
Dhaka 2
Fairmont 2
Genoa 2
Greensboro 2
Guayaquil 2
Totale 1.361
Nome #
Drug-Induced Acute Pancreatitis in Adults: Focus on Antimicrobial and Antiviral Drugs, a Narrative Review 400
Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases 275
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 178
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives 165
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 154
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools 137
Endoscopic Management of Strictures in Crohn’s Disease: An Unsolved Case 132
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 122
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 121
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment 120
Predictors of Efficacy of Janus Kinase Inhibitors in Patients Affected by Ulcerative Colitis 120
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 112
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 109
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 98
Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies 90
Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases? 90
Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders 84
Parenteral Nutrition, Inflammatory Bowel Disease, and Gut Barrier: An Intricate Plot 82
The inflammatory bowel disease care manager: Italian state of the art 74
Intestinal-Failure-Associated Liver Disease: Beyond Parenteral Nutrition 27
Neurofeedback as a non-pharmacological strategy for pain and gut-brain axis disorders: clinical relevance in inflammatory bowel disease 19
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology 15
Adverse Childhood Experiences and Disease Activity Are Associated with Post-Traumatic Stress Symptoms in Crohn’s Disease 11
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 8
Inflammatory bowel disease (IBD) is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity 6
Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: a pilot study 6
Psychopharmacological Therapy Positively Modulates Disease Activity in Inflammatory Bowel Disease: A Systematic Review 4
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective Study 4
Timing of biologic prophylaxis and postoperative recurrence in Crohn's disease: A real-life cohort study using propensity score weighting 3
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 1
Totale 2.767
Categoria #
all - tutte 9.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.584


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202324 0 0 0 0 0 0 0 0 4 1 3 16
2023/2024140 4 8 7 2 3 16 4 3 20 12 21 40
2024/2025502 5 9 24 23 28 15 45 10 48 70 117 108
2025/20261.519 177 59 115 232 202 85 195 87 110 92 68 97
2026/2027582 253 329 0 0 0 0 0 0 0 0 0 0
Totale 2.767